Cargando…
Serum level of co-expressed hub miRNAs as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma
Background: Sensitive and specific non-invasive biomarkers are urgently needed in order to improve the survival of patients with pancreatic ductal adenocarcinoma (PDAC), which is the fourth leading cause of cancer-related death. We aim to identify serum hub miRNAs as potential diagnostic and prognos...
Autores principales: | Su, Qiang, Zhu, Emily C, Qu, Yao-long, Wang, Di-ya, Qu, Wei-wei, Zhang, Chen-guang, Wu, Ting, Gao, Zu-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218787/ https://www.ncbi.nlm.nih.gov/pubmed/30410604 http://dx.doi.org/10.7150/jca.27697 |
Ejemplares similares
-
Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2017) -
miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review
por: Alemar, Bárbara, et al.
Publicado: (2015) -
Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2021) -
The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
por: Ren, Le, et al.
Publicado: (2018) -
Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis
por: Xin, Wenxiu, et al.
Publicado: (2023)